title: Vagus nerve stimulation as a strategy to prevent and manage metabolic syndrome.
abstract: An increase in pro-inflammatory cytokines, decrease in endothelial nitric oxide (eNO) and adiponectin levels and an alteration in hypothalamic peptides and gastrointestinal hormones such as incretins and cholecystokinin that regulate satiety, hunger, and food intake occur in metabolic syndrome. Thus, metabolic syndrome is a low-grade systemic inflammatory condition and could be due to inappropriate cross-talk between the peripheral tissues and the hypothalamic centers implying that methods designed to restore these two abnormalities to normal could be of significant benefit in metabolic syndrome. Vagus nerve stimulation has been shown to suppress inflammation and acetylcholine, the principal vagal neurotransmitter, modulates the actions of several hypothalamic peptides and incretins and cholecystokinin. Based on these evidences, it is proposed that vagus nerve stimulation could be of significant benefit in the management of the metabolic syndrome.
authors.affiliation: School of Biotechnology, Jawaharlal Nehru Technological University, Kakinada 533 003, India. undurti@hotmail.com
authors.forename: Undurti N
authors.initials: UN
authors.lastname: Das
mesh_terms: D000109:Acetylcholine / Q000502:physiology; D002766:Cholecystokinin / Q000378:metabolism / Q000502:physiology; D016207:Cytokines / Q000378:metabolism; D004435:Eating / Q000502:physiology; D005768:Gastrointestinal Hormones / Q000502:physiology; D006801:Humans; D006815:Hunger / Q000502:physiology; D007031:Hypothalamus / Q000378:metabolism; D007249:Inflammation / Q000378:metabolism; D024821:Metabolic Syndrome / Q000517:prevention & control* / Q000628:therapy*; D008954:Models, Biological; D010455:Peptides / Q000502:physiology; D012527:Satiation / Q000502:physiology; D055536:Vagus Nerve Stimulation / Q000379:methods*
chemical_list: D016207:Cytokines; D005768:Gastrointestinal Hormones; D010455:Peptides; D002766:Cholecystokinin; D000109:Acetylcholine